Dublin, May 27, 2020 (GLOBE NEWSWIRE) -- The "Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025 " report has been added to ResearchAndMarkets.com's offering.

The global microfluidics market size is projected to reach USD 44.0 billion by 2025 from USD 15.7 billion in 2020, at a CAGR of 22.9% during the forecast period.

The ability of the microfluidics technology to replicate all the functions of its traditional counterparts in various healthcare applications, such as drug delivery, point-of-care (POC) diagnostics, and clinical diagnostics, is resulting in its wider adoption across the globe. In addition to this, technological advancements, increasing focus on data precision & accuracy, fast returns on investment, and faster testing & improved portability through microfluidic chip miniaturization are driving the growth of the microfluidics industry.

In 2019, in-vitro diagnostics accounted for the largest share of the market.

Based on the application, the segment of the in-vitro diagnostics accounted for the largest share of the microfluidics market in 2019. The large share of this segment can be attributed to the increasing integration of microfluidics with laboratory analytical instruments, growing need for portable diagnostic equipment, and increasing demand for point-of-care testing.

In 2019, the hospitals & diagnostic centers segment accounted for the largest share of the market.

Based on end-users, the hospitals & diagnostic centers segment accounted for the largest share of the microfluidics market in 2019. The large share of this segment is attributed to the increasing use of microfluidic-based diagnostic devices, increasing adoption of microfluidics for the rapid diagnosis of various chronic diseases, technological advancements, and the inherent advantages of microfluidics

APAC is projected to witness the highest growth during the forecast period.

The APAC microfluidics market is estimated to register the highest CAGR during the forecast period. Factors such as the growing geriatric population, growing per capita income, increasing investments in the healthcare industry, rising demand for advanced technologies, and the expansion of private-sector hospitals to rural areas in various countries in the region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Growth Potential of the Microfluidics Market
4.2 Asia Pacific: Microfluidics Market, by End User
4.3 Microfluidics Market: Geographic Growth Opportunities
4.4 Microfluidics Market, by Region
4.5 Microfluidics Market: Developing Vs. Developed Markets

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Demand for Point-Of-Care Testing
5.2.1.2 Technological Advancements
5.2.1.3 Increasing Focus on Data Precision and Accuracy
5.2.1.4 Fast Returns on Investment
5.2.1.5 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization
5.2.1.6 Entry of New Players and Launch of New and Advanced Products
5.2.2 Restraints
5.2.2.1 Complex and Time-Consuming Regulatory Approval Process
5.2.2.2 Incorporation of Microfluidics Into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Emergence of Microfluidic-Based 3D Cell Culture Systems, Such As Organ-On-A-Chip
5.2.3.2 Asia - a Key Growth Hotspot
5.2.3.3 Expanding Applications of Drug Delivery Technologies
5.2.3.4 Growing Applications of Microfluidics
5.2.4 Challenges
5.2.4.1 Standardization/Commercialization of Microfluidic Devices

6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Shifting Trend Towards Ehealth Diagnostics with the Integration of Microfluidics-Based Poc Devices, Epidermal Electronics,And Iot
6.2.2 Adoption of 3D Printing in Microfluidics
6.2.3 Shifting Trend Towards the Adoption of Polymers
6.2.4 Universities Actively Investing in Microfluidic Startups and Large Players Acquiring Small Players
6.3 Analysis of Parent Markets
6.4 Evolution of Microfluidics in Healthcare
6.5 Value Chain Analysis
6.5.1 Microfluidic Components Procurement Model of Major Players

7 Microfluidics Market, by Product
7.1 Introduction
7.2 Microfluidic-Based Devices
7.2.1 Increasing Adoption of Microfluidic Devices Owing to the Various Advantages Offered by Them to Drive Market Growth
7.3 Microfluidic Components
7.3.1 Microfluidic Chips
7.3.1.1 Microfluidic Chips Reduce the Analysis Time by Increasing Automation and Consume Low Volumes of Samples
7.3.2 Flow and Pressure Sensors
7.3.2.1 These Devices Offer a Range of Advantages, Due to Which They Are Increasingly Used in Laboratories and Research Institutes
7.3.3 Flow and Pressure Controllers
7.3.3.1 Due to High Accuracy and Control Stability, Pressure Controllers Are Suitable As References for Laboratories
7.3.4 Micropumps
7.3.4.1 Need for Precision in Fluid Control and Device Miniaturization Has Favored the Growth of the Micropumps Market
7.3.5 Microfluidic Valves
7.3.5.1 Valves Are a Vital Component in Microfluidic Devices - a Key Factor Driving Market Growth
7.3.6 Microneedles
7.3.6.1 Small Size of Microneedles Leaves Dermal Nerves and Blood Vessels Unaffected, Ensuring a Painless Procedure
7.3.7 Other Components

8 Microfluidics Market, by Application
8.1 Introduction
8.2 in Vitro Diagnostics
8.2.1 Point-Of-Care Testing
8.2.1.1 Point-Of-Care Testing is the Largest Application Segment in the Microfluidics Market for in Vitro Diagnostics
8.2.2 Clinical Diagnostics
8.2.2.1 Increase in Viral Outbreaks to Drive Growth in the Clinical Diagnostics Segment
8.2.3 Veterinary Diagnostics
8.2.3.1 Growing Need for Low-Cost, Rapid, and Reliable Diagnostic Results in Veterinary Medicine to Drive Market Growth
8.3 Pharmaceutical and Life Science Research and Manufacturing
8.3.1 Lab Analytics
8.3.1.1 Proteomic Analysis
8.3.1.1.1 Increasing Demand for Rapid Proteomic Analysis for Drug Development is Boosting the Adoption of Lab-On-A-Chip Devices
8.3.1.2 Genomic Analysis
8.3.1.2.1 Increasing Focus on the Decoding of Genomes to Boost the Adoption of Microfluidics in Genomics
8.3.1.3 Cell-Based Assays
8.3.1.3.1 Increasing Focus on Microfluidic Cell-Based Assays for Rapid Drug Development Aids Market Growth
8.3.1.4 Capillary Electrophoresis
8.3.1.4.1 Combination of Microfluidic Capillary Electrophoresis with Other Technologies to Drive Overall Market Growth
8.3.2 Microdispensing
8.3.2.1 Advantages Such As Less Sample and Reagent Consumption and Ease of Operation Drive the Adoption of Microdispensing Systems
8.3.3 Microreaction
8.3.3.1 Increasing Need for Optimization in the Research and Production Process Using Microfluidic Techniques Drives the Market Growth
8.4 Therapeutics
8.4.1 Drug Delivery
8.4.1.1 Expanding Applications of Microfluidic in Development of Drug Delivery Platform Are a Key Driver for Market Growth
8.4.2 Wearable Devics
8.4.2.1 Increasing Demand for Microfluidics-Integrated Wearable Devices for Patient Vital Sign Monitoring Drives Overall Growth

9 Microfluidics Market, by End User
9.1 Introduction
9.2 Hospitals and Diagnostic Centers
9.2.1 Hospitals and Diagnostic Centers Are the Largest End Users of Microfluidics
9.3 Academic and Research Institutes
9.3.1 Use of Microfluidics in Research is Expected to Increase with Growing Funding in the Field
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Increasing Focus on Launching Quality Drugs to Support Market Growth

10 Microfluidics Market, by Region
10.1 Introduction
10.2 North America
10.2.1 Us
10.2.1.1 The US Dominates the North American Microfluidics Market
10.2.2 Canada
10.2.2.1 Strong Infrastructure and Availability of Funding for Biomedical Research Will Support Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Holds the Largest Share in the European Market
10.3.2 France
10.3.2.1 Genomics and Proteomics Research is Strongly Supported by the Government of France
10.3.3 UK
10.3.3.1 Increasing Incidence of Infectious Diseases Such As Covid-19 Drives the Growth of Poc Testing and Microfluidics
10.3.4 Italy
10.3.4.1 Increasing Demand for Poc Testing Aids Market Growth
10.3.5 Spain
10.3.5.1 Increasing Incidence of Infectious and Chronic Diseases Drives the Growth of the Market
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 China Holds a Major Share in the Asia Pacific Microfluidics Market
10.4.2 Japan
10.4.2.1 Adoption of Technologically Advanced Laboratory Analytical Instruments in Research to Drive Market Growth in Japan
10.4.3 India
10.4.3.1 Increasing Pharma R&D and Government Funding in the Biotechnology Sector is a Major Source of Market Growth
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.1.1 Pharmaceutical & Biologics Qc to Drive Market Growth in Brazil
10.5.2 Mexico
10.5.2.1 Rising Prevalence of Chronic Diseases Drives the Growth of the Microfluidics Market in Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa

11 Competitive Landscape
11.1 Overview
11.2 Product Portfolio Matrix
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Partnerships, Agreements, and Collaborations
11.3.3 Acquisitions
11.3.4 Expansions
11.4 Competitive Leadership Mapping
11.4.1 Visionary Leaders
11.4.2 Innovators
11.4.3 Dynamic Differentiators
11.4.4 Emerging Companies

12 Company Profiles
12.1 Parker-Hannifin Corporation
12.2 Smc Corporation
12.3 Idex Corporation
12.4 Fluigent Sa
12.5 Dolomite Microfluidics
12.6 Aignep S.P.A.
12.7 Camozzi Automation Spa Societ Unipersonale
12.8 Elveflow
12.9 Cellix Ltd.
12.10 Fortive Corporation
12.11 Danaher Corporation
12.12 Thermo Fisher Scientific Inc.
12.13 Perkinelmer, Inc.
12.14 Agilent Technologies, Inc.
12.15 Bio-Rad Laboratories, Inc.
12.16 Becton, Dickinson and Company
12.17 Illumina, Inc.
12.18 F. Hoffmann-La Roche Ltd.
12.19 Fluidigm Corporation
12.20 Abbott Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/he25d2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.